Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $499,246 | 33 | 99.4% |
| Food and Beverage | $3,196 | 33 | 0.6% |
| Education | $9.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc. | $467,926 | 25 | $0 (2018) |
| Greer Laboratories, Inc. | $31,320 | 8 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $737.30 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $596.57 | 6 | $0 (2024) |
| GENZYME CORPORATION | $445.75 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $397.37 | 4 | $0 (2024) |
| OptiNose US, Inc. | $279.30 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $147.65 | 2 | $0 (2024) |
| BioCryst US Sales Co., LLC | $124.99 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $122.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $648.34 | 7 | Novartis Pharmaceuticals Corporation ($147.65) |
| 2023 | $468.59 | 4 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2022 | $521.77 | 5 | OptiNose US, Inc. ($154.31) |
| 2021 | $124.99 | 1 | BioCryst US Sales Co., LLC ($124.99) |
| 2020 | $237.31 | 2 | AstraZeneca Pharmaceuticals LP ($125.01) |
| 2019 | $347.05 | 3 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2018 | $197,377 | 18 | Glenmark Pharmaceuticals Inc. ($165,707) |
| 2017 | $302,726 | 27 | Glenmark Pharmaceuticals Inc. ($302,220) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $113.88 | General |
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 03/21/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $110.29 | General |
| Category: Immunology and Neurology | ||||||
| 02/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: Immunology | ||||||
| 01/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $123.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 04/27/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: IMMUNOLOGY | ||||||
| 03/23/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $121.35 | General |
| Category: Immunology | ||||||
| 01/19/2023 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $100.43 | General |
| Category: Allergy | ||||||
| 10/20/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $118.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/18/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $135.02 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/18/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/20/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Immunology | ||||||
| 05/12/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $126.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 02/20/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Respiratory | ||||||
| 01/23/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $112.30 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $99.99 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 01/11/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $22,822.20 | Research |
| 11/09/2018 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/06/2018 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $28,551.60 | Research |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $215,520 | 13 |
| GSP 301-303 | Glenmark Pharmaceuticals Inc. | $86,700 | 5 |
| Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite HDM Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis | Greer Laboratories, Inc. | $31,320 | 8 |
About Dr. Robert Jacobs, M.D
Dr. Robert Jacobs, M.D is a Allergy & Immunology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669536330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Jacobs, M.D has received a total of $502,451 in payments from pharmaceutical and medical device companies, with $648.34 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "" ($499,246).
Practice Information
- Specialty Allergy & Immunology
- Location San Antonio, TX
- Active Since 12/20/2006
- Last Updated 10/08/2008
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1669536330
Products in Payments
- DUPIXENT (Biological) $634.47
- NUCALA (Biological) $596.57
- FASENRA (Drug) $352.89
- Xhance (Drug) $279.30
- AIRSUPRA (Drug) $124.99
- Orladeyo (Drug) $124.99
- DUPIXENT DUPILUMAB INJECTION (Biological) $123.03
- CINQAIR (Drug) $122.08
- Xembify (Biological) $110.29
- AUVI-Q (Drug) $100.43
- Hizentra (Biological) $98.48
- ATOPIC DERMATITIS - DISEASE (Drug) $85.62
- XOLAIR (Drug) $33.77
- OCTAGAM (Biological) $30.17
- ELIQUIS (Drug) $14.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in San Antonio
Dr. Joseph Diaz, M.d, M.D
Allergy & Immunology — Payments: $1.2M
Dr. Lukena Karkhanis, M.d, M.D
Allergy & Immunology — Payments: $293,175
Araceli Elizalde, Md, MD
Allergy & Immunology — Payments: $32,746
Dr. John Dice, M.d, M.D
Allergy & Immunology — Payments: $24,322
Ms. Jurairat Molina, Md, MD
Allergy & Immunology — Payments: $16,040
Kristin Bussey-Smith, Md, MD
Allergy & Immunology — Payments: $15,247